Singapore markets closed
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,070.55 +59.95 (+1.20%) Dow
38,503.69 +263.71 (+0.69%) Nasdaq
15,696.64 +245.33 (+1.59%) Bitcoin USD
66,361.53 +283.78 (+0.43%) CMC Crypto 200
1,431.29 +7.19 (+0.50%)
Merrimack Pharmaceuticals, Inc. (MACK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 213.98M |
| Enterprise value | 195.11M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 11.41 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -89.66 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.43 |
| 52-week change 3 | 21.23% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 15.89 |
| 52-week low 3 | 11.53 |
| 50-day moving average 3 | 14.70 |
| 200-day moving average 3 | 13.09 |
Share statistics
| Avg vol (3-month) 3 | 130.25k |
| Avg vol (10-day) 3 | 98.08k |
| Shares outstanding 5 | 14.53M |
| Implied shares outstanding 6 | 14.53M |
| Float 8 | 9.4M |
| % held by insiders 1 | 1.21% |
| % held by institutions 1 | 66.59% |
| Shares short (28 Mar 2024) 4 | 722.75k |
| Short ratio (28 Mar 2024) 4 | 6.23 |
| Short % of float (28 Mar 2024) 4 | 7.08% |
| Short % of shares outstanding (28 Mar 2024) 4 | 4.97% |
| Shares short (prior month 29 Feb 2024) 4 | 774.1k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 23 Dec 2019 |
| Ex-dividend date 4 | 13 Dec 2019 |
| Last split factor 2 | 1271:1000 |
| Last split date 3 | 06 Sept 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -6.97% |
| Return on equity (ttm) | -6.22% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -1.18M |
| Diluted EPS (ttm) | -0.08 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 18.88M |
| Total cash per share (mrq) | 1.3 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 43.50 |
| Book value per share (mrq) | 1.31 |
Cash flow statement
| Operating cash flow (ttm) | -1.52M |
| Levered free cash flow (ttm) | -1.13M |
© 2024 Yahoo. All rights reserved.